Theravance Inc (NASDAQ:THRX)

23.56
Data as of Aug 29
 +0.60 / +2.61%
Today’s Change
20.23
Today|||52-Week Range
34.52
-17.96%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Glaxosmithkline Plc
Buy2/11/2014342,229$37.77$12.9M-37.62%
Glaxosmithkline Plc
Buy5/09/2014317,770$26.86$8.5M-12.29%
Glaxosmithkline Plc
Buy10/29/2013130,473$37.53$4.9M-37.22%
Glaxosmithkline Plc
Buy8/11/2014172,651$22.13$3.8M+6.46%
Shafer Bradford J
General Counsel & Senior Vice President
Sale3/03/201464,006$36.72$2.4M-36.12%
Winningham Rick E
Chief Executive Officer
Sale5/09/201450,225$26.86$1.3M-12.29%
Lee Junning
Senior Vice President-Technical Operations
Sale8/13/201453,424$22.50$1.2M+4.11%
Mammen Mathai
Senior VP-Research & Early Clinical Development
Sale2/14/201430,400$39.26$1.2M-40.58%
Winningham Rick E
Chief Executive Officer
Sale9/12/201322,353$40.03$894.8K-42.80%
Shafer Bradford J
General Counsel & Senior Vice President
Buy3/03/201465,806$9.69$637.7K-36.12%
Page of 10

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.